Systematic Reviews
Copyright ©The Author(s) 2021.
World J Clin Cases. Jan 6, 2021; 9(1): 102-117
Published online Jan 6, 2021. doi: 10.12998/wjcc.v9.i1.102
Table 1 General characteristics of included systematic reviews
Ref.
Included study design, n
Total sample size
Intervention
Comparator
Evaluation of methodological quality
Outcomes
Cai et al[9], 2019RCT, 131429TCM formulas based on HuoXueHuaYu principleConventional medicationsCochrane Risk of Bias ToolUltrasound improvement rate, blood lipid profiles (TC, TG), hepatic function (ALT, AST), global improvement rate
Shi et al[8], 2012RCT, 625904TCM formulas, alone or in combination with conventional medicationsPlacebo or conventional medicationsNot mentionedALT normalization rate, blood lipids normalization rate, hepatic steatosis disappearance rate
He et al[16], 2010RCT, 111078TCM formulas, aloneConventional medicationsJadad ScaleHepatic function (ALT, AST, GGT), blood lipid profiles (TC, TG, HDL-C)
Li et al[17], 2011RCT, 222442TCM formulas, aloneConventional medicationsSchulz and Jadad CriteriaCure rate, global improvement rate, hepatic function (ALT, AST, GGT), blood lipid profiles (TC, TG, HDL-C, LDL-C)
Li et al[18], 2014RCT, 171552TCM formulas, alone or in combination with polyene phosphatidyl cholinePolyene phosphatidyl cholineNot mentionedGlobal improvement rate
Yang et al[19], 2019RCT, 191490TCM formulas based on JianPiHuaTan principle, alone or in combination with conventional medicationsConventional medicationsJadad ScaleGlobal improvement rate, hepatic function (ALT, AST), blood lipid profiles (TC, TG), adverse events
Zhang et al[20], 2014RCT, 101395TCM formulas alonePlacebo or conventional medicationsJadad ScaleGlobal improvement rate, adverse events